4//SEC Filing
Morningside Venture Investments Ltd 4
Accession 0000899243-23-009506
CIK 0001658551other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 4:05 PM ET
Size
7.6 KB
Accession
0000899243-23-009506
Insider Transaction Report
Form 4
Morningside Venture Investments Ltd
10% Owner
Transactions
- Sale
Common Stock
2023-03-21$32.17/sh−28,807$926,721→ 7,187,314 total - Sale
Common Stock
2023-03-21$31.69/sh−34,641$1,097,773→ 7,216,121 total
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $32.00, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.005 to $32.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001543112
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 4:05 PM ET
- Size
- 7.6 KB